US Growth Companies With High Insider Ownership

As major U.S. indexes look to recover from their worst week of the year, investors are keenly observing market movements and economic indicators. In this environment, growth companies with high insider ownership can offer unique insights and potential stability, as insiders' vested interests often align closely with shareholder value.

Top 10 Growth Companies With High Insider Ownership In The United States

Name	Insider Ownership	Earnings Growth
Atour Lifestyle Holdings (NasdaqGS:ATAT)	26%	23.2%
Atlas Energy Solutions (NYSE:AESI)	29.1%	42.1%
GigaCloud Technology (NasdaqGM:GCT)	25.7%	24.3%
Victory Capital Holdings (NasdaqGS:VCTR)	10.2%	32.3%
Super Micro Computer (NasdaqGS:SMCI)	25.7%	27.1%
Hims & Hers Health (NYSE:HIMS)	13.7%	40.7%
On Holding (NYSE:ONON)	28.4%	24.4%
Credo Technology Group Holding (NasdaqGS:CRDO)	14.1%	95.9%
EHang Holdings (NasdaqGM:EH)	32.8%	81.5%
BBB Foods (NYSE:TBBB)	22.9%	91.3%

Click here to see the full list of 180 stocks from our Fast Growing US Companies With High Insider Ownership screener.

We'll examine a selection from our screener results.

Corcept Therapeutics (NasdaqCM:CORT)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Corcept Therapeutics Incorporated focuses on discovering and developing drugs for severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States with a market cap of $3.59 billion.

Operations: The company generates $569.61 million from the discovery, development, and commercialization of pharmaceutical products.

Insider Ownership: 11.6%

Corcept Therapeutics, a growth company with high insider ownership, is forecasted to achieve 19.4% annual revenue growth, outpacing the US market's 8.5%. Its earnings are expected to grow significantly at 37.47% per year over the next three years. Recent events include raised revenue guidance for 2024 to US$640 million-US$670 million and Q2 net income of US$35.49 million, up from US$27.53 million a year ago, reflecting strong financial performance amidst limited insider trading activity in recent months.

• Click here to discover the nuances of Corcept Therapeutics with our detailed analytical future growth report.
• Our expertly prepared valuation report Corcept Therapeutics implies its share price may be lower than expected.

Marcus & Millichap (NYSE:MMI)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Marcus & Millichap, Inc. (NYSE:MMI) is an investment brokerage company offering real estate investment brokerage and financing services to commercial real estate buyers and sellers in the United States and Canada, with a market cap of $1.46 billion.

Operations: The company generates $615.74 million from delivering commercial real estate services.

Insider Ownership: 36.6%

Marcus & Millichap is forecasted to achieve revenue growth of 28.6% per year, significantly outpacing the US market's 8.5%. The company is expected to become profitable within three years, with earnings projected to grow at an impressive rate of 155.83% annually. Despite recent financial challenges, including a Q2 net loss of US$5.54 million and a six-month net loss of US$15.53 million, the stock trades at 33.2% below its estimated fair value, indicating potential for future gains amidst high insider ownership levels.

• Take a closer look at Marcus & Millichap's potential here in our earnings growth report.
• The analysis detailed in our Marcus & Millichap valuation report hints at an inflated share price compared to its estimated value.

BBB Foods (NYSE:TBBB)

Simply Wall St Growth Rating: ★★★★★★

Overview: BBB Foods Inc., through its subsidiaries, operates a chain of grocery retail stores in Mexico and has a market cap of $3.22 billion.

Operations: The company's revenue segment includes the sale, acquisition, and distribution of all types of products and consumer goods, amounting to MX$49.99 billion.

Insider Ownership: 22.9%

BBB Foods is forecasted to achieve annual revenue growth of 22.6%, outpacing the US market's 8.5%. The company is expected to become profitable within three years, with earnings projected to grow at 91.32% annually and a high return on equity forecasted at 26.8%. Despite trading at 72.5% below its estimated fair value, recent earnings reports show substantial revenue increases but mixed net income results for the six-month period ending June 30, 2024.

• Dive into the specifics of BBB Foods here with our thorough growth forecast report.
• Our expertly prepared valuation report BBB Foods implies its share price may be too high.

Seize The Opportunity

• Reveal the 180 hidden gems among our Fast Growing US Companies With High Insider Ownership screener with a single click here.
• Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
• Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com